Farallon Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.5M | Buy |
4,529,318
+195,000
| +4% | +$2.56M | 0.26% | 48 |
|
|
2025
Q1 | $62.3M | Buy |
4,334,318
+835,609
| +24% | +$12M | 0.31% | 49 |
|
|
2024
Q4 | $58.6M | Buy |
3,498,709
+684,391
| +24% | +$11.5M | 0.26% | 49 |
|
|
2024
Q3 | $45M | Buy |
2,814,318
+818,318
| +41% | +$13.1M | 0.2% | 62 |
|
|
2024
Q2 | $18M | Buy |
1,996,000
+1,625,000
| +438% | +$14.7M | 0.08% | 71 |
|
|
2024
Q1 | $4.19M | Buy |
+371,000
| New | +$4.19M | 0.02% | 101 |
|